Drug profile · INN
mercaptamine bitartrate
CYSTAGON
mercaptamine bitartrate (CYSTAGON) is a cystine reducing agent.
EMA: approved Alimentary tract and metabolism (A16) A16AA04
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — mercaptamine bitartrate
- Class
- Alimentary tract and metabolism (A16)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
mercaptamine bitartrate (CYSTAGON) is a cystine reducing agent.
Key facts
INN mercaptamine bitartrate
Brand CYSTAGON
Mechanism Cystine reducing agent
Target Cystine
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AA04
Mechanism of action
Cystine reducing agent
Primary target: Cystine
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is mercaptamine bitartrate?
mercaptamine bitartrate (CYSTAGON) is a cystine reducing agent.
What is the brand name for mercaptamine bitartrate?
CYSTAGON is a marketed brand name for mercaptamine bitartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.